Portfolio Holdings Detail for ISIN IE000G4PH2B1
Stock Name / FundiShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity Type
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerUPAD(USD) LSE
ETF TickerUPAD.L(GBP) LSE

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-12-03 (Wednesday)4,669USD 4,825,692LLY holding decreased by -58642USD 4,825,6920USD -58,642 USD 1033.56 USD 1046.12
2025-12-02 (Tuesday)4,669LLY holding decreased by -102USD 4,884,334LLY holding decreased by -162859USD 4,884,334-102USD -162,859 USD 1046.12 USD 1057.89
2025-12-01 (Monday)4,771USD 5,047,193LLY holding decreased by -83874USD 5,047,1930USD -83,874 USD 1057.89 USD 1075.47
2025-11-28 (Friday)4,771LLY holding decreased by -34USD 5,131,067LLY holding decreased by -175287USD 5,131,067-34USD -175,287 USD 1075.47 USD 1104.34
2025-11-27 (Thursday)4,805USD 5,306,354USD 5,306,3540USD 0 USD 1104.34 USD 1104.34
2025-11-26 (Wednesday)4,805USD 5,306,354LLY holding decreased by -26908USD 5,306,3540USD -26,908 USD 1104.34 USD 1109.94
2025-11-25 (Tuesday)4,805LLY holding increased by 34USD 5,333,262LLY holding increased by 227529USD 5,333,26234USD 227,529 USD 1109.94 USD 1070.16
2025-11-24 (Monday)4,771USD 5,105,733LLY holding increased by 49904USD 5,105,7330USD 49,904 USD 1070.16 USD 1059.7
2025-11-21 (Friday)4,771USD 5,055,829LLY holding increased by 78292USD 5,055,8290USD 78,292 USD 1059.7 USD 1043.29
2025-11-20 (Thursday)4,771LLY holding increased by 17USD 4,977,537LLY holding decreased by -12261USD 4,977,53717USD -12,261 USD 1043.29 USD 1049.6
2025-11-19 (Wednesday)4,754LLY holding decreased by -34USD 4,989,798LLY holding increased by 57919USD 4,989,798-34USD 57,919 USD 1049.6 USD 1030.05
2025-11-18 (Tuesday)4,788USD 4,931,879LLY holding increased by 39979USD 4,931,8790USD 39,979 USD 1030.05 USD 1021.7
2025-11-17 (Monday)4,788LLY holding decreased by -136USD 4,891,900LLY holding decreased by -156579USD 4,891,900-136USD -156,579 USD 1021.7 USD 1025.28
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE000G4PH2B1

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02SELL-1021,068.1801,040.360 1,043.142EUR -106,400 821.27 Loss of -22,631 on sale
2025-11-28SELL-341,098.8701,067.800 1,070.907EUR -36,411 819.04 Loss of -8,564 on sale
2025-11-25BUY341,111.1101,073.250 1,077.036EUR 36,619 815.07
2025-11-20BUY171,057.0001,038.250 1,040.125EUR 17,682 811.66
2025-11-19SELL-341,055.5501,026.250 1,029.180EUR -34,992 810.55 Loss of -7,434 on sale
2025-11-17SELL-1361,032.141998.302 1,001.685EUR -136,229 808.51 Loss of -26,272 on sale
2025-11-03SELL-425901.339862.680 866.546EUR -368,282 800.91 Loss of -27,896 on sale
2025-10-31BUY17869.910834.950 838.446EUR 14,254 800.60
2025-10-23SELL-68821.040824.700 824.334EUR -56,055 799.84 Loss of -1,666 on sale
2025-10-22SELL-34812.430815.940 815.589EUR -27,730 799.77 Loss of -538 on sale
2025-10-07SELL-306843.630848.540 848.049EUR -259,503 799.16 Loss of -14,961 on sale
2025-10-06BUY34845.050856.570 855.418EUR 29,084 798.91
2025-10-01SELL-17825.420833.300 832.512EUR -14,153 798.42 Loss of -580 on sale
2025-09-29SELL-289726.510727.860 727.725EUR -210,313 799.02 Profit of 20,604 on sale
2025-09-24BUY536741.850746.940 746.431EUR 400,087 800.24
2025-09-18BUY16762.930772.540 771.579EUR 12,345 800.45
2025-09-10SELL-32754.620755.800 755.682EUR -24,182 801.76 Profit of 1,474 on sale
2025-08-20BUY80705.440705.800 705.764EUR 56,461 804.45
2025-08-15SELL-32701.230706.790 706.234EUR -22,599 806.37 Profit of 3,204 on sale
2025-07-21SELL-64762.180772.000 771.018EUR -49,345 807.87 Profit of 2,359 on sale
2025-07-17BUY16761.500790.000 787.150EUR 12,594 808.42
2025-07-15SELL-112771.750805.420 802.053EUR -89,830 808.79 Profit of 755 on sale
2025-07-09SELL-32786.920794.000 793.292EUR -25,385 808.94 Profit of 501 on sale
2025-07-03SELL-32780.670783.550 783.262EUR -25,064 809.80 Profit of 849 on sale
2025-07-02SELL-160779.280779.840 779.784EUR -124,765 810.01 Profit of 4,837 on sale
2025-06-30SELL-464779.530785.000 784.453EUR -363,986 810.23 Profit of 11,959 on sale
2025-06-13SELL-232819.360825.000 824.436EUR -191,269 811.45 Loss of -3,012 on sale
2025-06-12SELL-174812.030818.560 817.907EUR -142,316 811.45 Loss of -1,124 on sale
2025-06-11SELL-522808.610820.720 819.509EUR -427,784 811.47 Loss of -4,197 on sale
2025-06-10SELL-638807.190808.630 808.486EUR -515,814 811.50 Profit of 1,924 on sale
2025-06-05BUY174765.680770.000 769.568EUR 133,905 812.49
2025-05-19SELL-29755.110758.720 758.359EUR -21,992 821.47 Profit of 1,830 on sale
2025-05-13BUY87746.060759.500 758.156EUR 65,960 824.50
2025-05-02BUY116823.620831.530 830.739EUR 96,366 827.74
2025-05-01SELL-145794.100850.930 845.247EUR -122,561 828.07 Loss of -2,491 on sale
2025-04-28SELL-493877.290882.250 881.754EUR -434,705 826.28 Loss of -27,350 on sale
2025-04-16BUY116734.900756.300 754.160EUR 87,483 826.01
2025-04-08BUY174726.240763.500 759.774EUR 132,201 832.03
2025-04-07SELL-464723.730748.000 745.573EUR -345,946 833.32 Profit of 40,714 on sale
2025-04-04SELL-87738.210768.270 765.264EUR -66,578 834.46 Profit of 6,020 on sale
2025-03-28SELL-1,450822.510829.780 829.053EUR -1,202,127 835.30 Profit of 9,058 on sale
2025-03-27SELL-58821.670826.770 826.260EUR -47,923 835.47 Profit of 534 on sale
2025-03-24SELL-58864.900866.870 866.673EUR -50,267 834.97 Loss of -1,839 on sale
2025-03-21BUY146837.570850.430 849.144EUR 123,975 834.94
2025-03-18SELL-696822.510836.290 834.912EUR -581,099 834.98 Profit of 45 on sale
2025-03-14SELL-192813.480815.210 815.037EUR -156,487 835.44 Profit of 3,917 on sale
2025-03-13SELL-29801.650821.110 819.164EUR -23,756 835.93 Profit of 486 on sale
2025-03-12BUY290821.860834.650 833.371EUR 241,678 836.14
2025-03-11BUY377824.060832.350 831.521EUR 313,483 836.33
2025-03-07BUY174869.580908.000 904.158EUR 157,323 835.91
2025-03-05BUY377929.720930.490 930.413EUR 350,766 834.42
2025-02-26BUY58915.010922.430 921.688EUR 53,458 827.36
2025-02-12BUY58872.970877.780 877.299EUR 50,883 818.74
2025-02-05BUY116842.180846.900 846.428EUR 98,186 813.36
2025-01-02BUY153778.070787.000 786.107EUR 120,274 816.86
2024-12-09SELL-30803.580823.700 821.688EUR -24,651 817.85 Loss of -115 on sale
2024-12-03SELL-60813.330817.130 816.750EUR -49,005 816.95 Profit of 12 on sale
2024-12-02BUY30799.800805.350 804.795EUR 24,144 817.61
2024-11-29BUY60795.350800.330 799.832EUR 47,990 818.50
2024-11-27BUY150788.190794.830 794.166EUR 119,125 821.14
2024-11-26BUY180789.320807.000 805.232EUR 144,942 822.59
2024-11-22BUY60748.010761.280 759.953EUR 45,597 829.70
2024-11-19BUY60729.730730.000 729.973EUR 43,798 844.76
2024-11-18BUY90727.200734.000 733.320EUR 65,999 852.10
2024-11-12BUY30818.860833.990 832.477EUR 24,974 854.32
2024-11-05BUY300806.060809.210 808.895EUR 242,669 873.03
2024-10-31BUY120829.740853.500 851.124EUR 102,135 893.57
2024-10-30BUY450846.830860.500 859.133EUR 386,610 900.25
2024-10-21BUY60906.130918.860 917.587EUR 55,055 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy